MedTrace Logo

Sustainable Healthcenter Implementation PrEP Pilot Study

NCT02074891 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1420

Last updated 2024-05-28

No results posted yet for this study

Summary

A health services implementation pilot study, conducted with an observational cohort of HIV-uninfected persons including men who have sex with men, heterosexual women and men, and injection drug users receiving daily oral antiretroviral preexposure prophylaxis (PrEP) at four federally qualified health centers that provide sexual health and primary care services to communities with high HIV incidence/prevalence.

Conditions

  • HIV Chemoprophylaxis
  • HIV Preexposure Prophylaxis

Interventions

DRUG

coformulated TDF/FTC

Daily oral dose of coformulated TDF/FTC

Sponsors & Collaborators

Principal Investigators

  • Dawn K Smith, MD, MS, MPH · Centers for Disease Control and Prevention

  • Rebecca Cook, MPH · CDC Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02074891 on ClinicalTrials.gov